{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:02:57Z","timestamp":1789729377613,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,25]],"date-time":"2015-07-25T00:00:00Z","timestamp":1437782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s10549-015-3508-y","type":"journal-article","created":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T13:56:18Z","timestamp":1437746178000},"page":"21-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer"],"prefix":"10.1007","volume":"153","author":[{"given":"Parvin","family":"Forghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund K.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,25]]},"reference":[{"issue":"7","key":"3508_CR1","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1078-0432.CCR-10-2672","volume":"17","author":"C Zoglmeier","year":"2011","unstructured":"Zoglmeier C, Bauer H, Norenberg D, Wedekind G, Bittner P, Sandholzer N, Rapp M, Anz D, Endres S, Bourquin C (2011) CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice. Clin Cancer Res 17(7):1765\u20131775","journal-title":"Clin Cancer Res"},{"key":"3508_CR2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.intimp.2011.01.030","volume":"11","author":"J Finke","year":"2011","unstructured":"Finke J (2011) MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic. Inter Immunopharmacol 11:856","journal-title":"Inter Immunopharmacol"},{"issue":"2","key":"3508_CR3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00296-012-2381-9","volume":"33","author":"H Nakamura","year":"2013","unstructured":"Nakamura H, Horai Y, Suzuki T, Okada A, Ichinose K, Yamasaki S, Koji T, Kawakami A (2013) TLR3-mediated apoptosis and activation of phosphorylated Akt in the salivary gland epithelial cells of primary Sjogren\u2019s syndrome patients. Rheumatol Int 33(2):441\u2013450","journal-title":"Rheumatol Int"},{"issue":"1","key":"3508_CR4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-013-2618-7","volume":"140","author":"J Markowitz","year":"2013","unstructured":"Markowitz J, Wesolowski R, Papenfuss T, Brooks TR, Carson WE 3rd (2013) Myeloid-derived suppressor cells in breast cancer. Breast Cancer Res Treat 140(1):13\u201321","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"3508_CR5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00262-011-1132-1","volume":"61","author":"N Harashima","year":"2012","unstructured":"Harashima N, Inao T, Imamura R, Okano S, Suda T, Harada M (2012) Roles of the PI3\u00a0K\/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells. Cancer Immunol Immunother 61(5):667\u2013676","journal-title":"Cancer Immunol Immunother"},{"issue":"18","key":"3508_CR6","doi-asserted-by":"crossref","first-page":"15918","DOI":"10.1074\/jbc.M110.178798","volume":"286","author":"R Sun","year":"2011","unstructured":"Sun R, Zhang Y, Lv Q, Liu B, Jin M, Zhang W, He Q, Deng M, Liu X, Li G et al (2011) Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha). J Biol Chem 286(18):15918\u201315928","journal-title":"J Biol Chem"},{"issue":"7","key":"3508_CR7","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1349-7006.2010.01567.x","volume":"101","author":"M Taura","year":"2010","unstructured":"Taura M, Fukuda R, Suico MA, Eguma A, Koga T, Shuto T, Sato T, Morino-Koga S, Kai H (2010) TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis. Cancer Sci 101(7):1610\u20131617","journal-title":"Cancer Sci"},{"issue":"17","key":"3508_CR8","doi-asserted-by":"crossref","first-page":"7843","DOI":"10.18632\/oncotarget.2279","volume":"5","author":"T Liechtenstein","year":"2014","unstructured":"Liechtenstein T, Perez-Janices N, Gato M, Caliendo F, Kochan G, Blanco-Luquin I, Van der Jeught K, Arce F, Guerrero-Setas D, Fernandez-Irigoyen J et al (2014) A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice. Oncotarget 5(17):7843\u20137857","journal-title":"Oncotarget"},{"issue":"6","key":"3508_CR9","doi-asserted-by":"crossref","first-page":"984","DOI":"10.4161\/onci.20201","volume":"1","author":"T Ghansah","year":"2012","unstructured":"Ghansah T (2012) A novel strategy for modulation of MDSC to enhance cancer immunotherapy. Oncoimmunology 1(6):984\u2013985","journal-title":"Oncoimmunology"},{"issue":"3","key":"3508_CR10","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.ajpath.2010.11.078","volume":"178","author":"G Mignot","year":"2011","unstructured":"Mignot G, Chalmin F, Ladoire S, R\u00e9b\u00e9 C, Ghiringhelli F (2011) Tumor exosome-mediated MDSC activation. Am J pathol 178(3):1403\u20131405","journal-title":"Am J pathol"},{"issue":"1","key":"3508_CR11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yexmp.2014.05.003","volume":"97","author":"TL Green","year":"2014","unstructured":"Green TL, Santos MF, Ejaeidi AA, Craft BS, Lewis RE, Cruse JM (2014) Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells. Exp Mol Pathol 97(1):44\u201348","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"3508_CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00262-008-0523-4","volume":"58","author":"CM Diaz-Montero","year":"2009","unstructured":"Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ (2009) Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother 58(1):49\u201359","journal-title":"Cancer Immunol Immunother"},{"issue":"10","key":"3508_CR13","first-page":"3181","volume":"7","author":"N Chi","year":"2014","unstructured":"Chi N, Tan Z, Ma K, Bao L, Yun Z (2014) Increased circulating myeloid-derived suppressor cells correlate with cancer stages, interleukin-8 and -6 in prostate cancer. Int J Clin Exp Med 7(10):3181\u20133192","journal-title":"Int J Clin Exp Med"},{"issue":"8","key":"3508_CR14","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.4049\/jimmunol.176.8.4894","volume":"176","author":"B Salaun","year":"2006","unstructured":"Salaun B, Coste I, Rissoan MC, Lebecque SJ, Renno T (2006) TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 176(8):4894\u20134901","journal-title":"J Immunol"},{"issue":"12","key":"3508_CR15","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4161\/cbt.10.12.13450","volume":"10","author":"YS Cheng","year":"2010","unstructured":"Cheng YS, Xu F (2010) Anticancer function of polyinosinic-polycytidylic acid. Cancer Biol Ther 10(12):1219\u20131223","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"3508_CR16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/cam4.186","volume":"3","author":"P Forghani","year":"2014","unstructured":"Forghani P, Khorramizadeh MR, Waller EK (2014) Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer. Cancer Med 3(2):215\u2013224","journal-title":"Cancer Med"},{"key":"3508_CR17","first-page":"1488","volume":"35","author":"a Ray","year":"2010","unstructured":"Ray A, Dittel BN (2010) Isolation of mouse peritoneal cavity cells. J Vis Exp 35:1488","journal-title":"J Vis Exp"},{"issue":"7","key":"3508_CR18","doi-asserted-by":"crossref","first-page":"e64837","DOI":"10.1371\/journal.pone.0064837","volume":"8","author":"P Forghani","year":"2013","unstructured":"Forghani P, Harris W, Giver CR, Mirshafiey A, Galipeau J, Waller EK (2013) Properties of immature myeloid progenitors with nitric-oxide-dependent immunosuppressive activity isolated from bone marrow of tumor-free mice. PLoS ONE 8(7):e64837","journal-title":"PLoS ONE"},{"issue":"8","key":"3508_CR19","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00262-012-1269-6","volume":"61","author":"S Ostrand-Rosenberg","year":"2012","unstructured":"Ostrand-Rosenberg S, Sinha P, Chornoguz O, Ecker C (2012) Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC). Cancer Immunol Immunother 61(8):1319\u20131325","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"3508_CR20","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.4049\/jimmunol.181.7.4666","volume":"181","author":"P Sinha","year":"2008","unstructured":"Sinha P, Okoro C, Foell D, Freeze HH, Ostrand-Rosenberg S, Srikrishna G (2008) Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol 181(7):4666\u20134675","journal-title":"J Immunol"},{"key":"3508_CR21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1479-5876-9-223","volume":"9","author":"J Fucikova","year":"2011","unstructured":"Fucikova J, Rozkova D, Ulcova H, Budinsky V, Sochorova K, Pokorna K, Bartunkova J, Spisek R (2011) Poly I: C-activated dendritic cells that were generated in Cell Gro for use in cancer immunotherapy trials. J Trans Med 9:223","journal-title":"J Trans Med"},{"issue":"1","key":"3508_CR22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4049\/jimmunol.163.1.57","volume":"163","author":"RM Verdijk","year":"1999","unstructured":"Verdijk RM, Mutis T, Esendam B, Kamp J, Melief CJ, Brand A, Goulmy E (1999) Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol 163(1):57\u201361","journal-title":"J Immunol"},{"issue":"5","key":"3508_CR23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/CJI.0b013e318177d9e5","volume":"31","author":"I Moller","year":"2008","unstructured":"Moller I, Michel K, Frech N, Burger M, Pfeifer D, Frommolt P, Veelken H, Thomas-Kaskel AK (2008) Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application. J Immunother 31(5):506\u2013519","journal-title":"J Immunother"},{"issue":"4","key":"3508_CR24","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1158\/0008-5472.CAN-11-2863","volume":"72","author":"S Nagaraj","year":"2012","unstructured":"Nagaraj S, Nelson A, Youn JI, Cheng P, Quiceno D, Gabrilovich DI (2012) Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling. Cancer Res 72(4):928\u2013938","journal-title":"Cancer Res"},{"issue":"2","key":"3508_CR25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1158\/0008-5472.CAN-06-2941","volume":"67","author":"H Kulbe","year":"2007","unstructured":"Kulbe H, Thompson R, Wilson JL, Robinson S, Hagemann T, Fatah R, Gould D, Ayhan A, Balkwill F (2007) The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res 67(2):585\u2013592","journal-title":"Cancer Res"},{"issue":"10","key":"3508_CR26","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1172\/JCI39065","volume":"119","author":"KA Charles","year":"2009","unstructured":"Charles KA, Kulbe H, Soper R, Escorcio-Correia M, Lawrence T, Schultheis A, Chakravarty P, Thompson RG, Kollias G, Smyth JF et al (2009) The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J Clin Invest 119(10):3011\u20133023","journal-title":"J Clin Invest"},{"issue":"5","key":"3508_CR27","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1158\/0008-5472.CAN-10-3490","volume":"71","author":"B Salaun","year":"2011","unstructured":"Salaun B, Zitvogel L, Asselin-Paturel C, Morel Y, Chemin K, Dubois C, Massacrier C, Conforti R, Chenard MP, Sabourin JC et al (2011) TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer. Cancer Res 71(5):1607\u20131614","journal-title":"Cancer Res"},{"issue":"6","key":"3508_CR28","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1189\/jlb.0708446","volume":"85","author":"SK Bunt","year":"2009","unstructured":"Bunt SK, Clements VK, Hanson EM, Sinha P, Ostrand-Rosenberg S (2009) Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4. J Leukoc Biol 85(6):996\u20131004","journal-title":"J Leukoc Biol"},{"issue":"4","key":"3508_CR29","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/hep.26915","volume":"59","author":"E Conrad","year":"2014","unstructured":"Conrad E, Resch TK, Gogesch P, Kalinke U, Bechmann I, Bogdan C, Waibler Z (2014) Protection against RNA-induced liver damage by myeloid cells requires type I interferon and IL-1 receptor antagonist in mice. Hepatology 59(4):1555\u20131563","journal-title":"Hepatology"},{"issue":"9","key":"3508_CR30","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1158\/0008-5472.CAN-10-3259","volume":"71","author":"F Aranda","year":"2011","unstructured":"Aranda F, Llopiz D, Diaz-Valdes N, Riezu-Boj JI, Bezunartea J, Ruiz M, Martinez M, Durantez M, Mansilla C, Prieto J et al (2011) Adjuvant combination and antigen targeting as a strategy to induce polyfunctional and high-avidity T-cell responses against poorly immunogenic tumors. Cancer Res 71(9):3214\u20133224","journal-title":"Cancer Res"},{"issue":"7","key":"3508_CR31","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/carcin\/bgn149","volume":"29","author":"A Paone","year":"2008","unstructured":"Paone A, Starace D, Galli R, Padula F, De Cesaris P, Filippini A, Ziparo E, Riccioli A (2008) Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism. Carcinogenesis 29(7):1334\u20131342","journal-title":"Carcinogenesis"},{"issue":"11","key":"3508_CR32","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.4049\/jimmunol.1103811","volume":"188","author":"G Forte","year":"2012","unstructured":"Forte G, Rega A, Morello S, Luciano A, Arra C, Pinto A, Sorrentino R (2012) Polyinosinic-polycytidylic acid limits tumor outgrowth in a mouse model of metastatic lung cancer. J Immunol 188(11):5357\u20135364","journal-title":"J Immunol"},{"issue":"3","key":"3508_CR33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000355126","volume":"6","author":"H Shime","year":"2014","unstructured":"Shime H, Kojima A, Maruyama A, Saito Y, Oshiumi H, Matsumoto M, Seya T (2014) Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models. J Innate Immun 6(3):293\u2013305","journal-title":"J Innate Immun"},{"issue":"4","key":"3508_CR34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.semcancer.2012.01.011","volume":"22","author":"S Ostrand-Rosenberg","year":"2012","unstructured":"Ostrand-Rosenberg S, Sinha P, Beury DW, Clements VK (2012) Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Semin Cancer Biol 22(4):275\u2013281","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"3508_CR35","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1158\/0008-5472.CAN-12-2418","volume":"73","author":"T Dalotto-Moreno","year":"2013","unstructured":"Dalotto-Moreno T, Croci DO, Cerliani JP, Martinez-Allo VC, Dergan-Dylon S, Mendez-Huergo SP, Stupirski JC, Mazal D, Osinaga E, Toscano MA et al (2013) Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease. Cancer Res 73(3):1107\u20131117","journal-title":"Cancer Res"},{"issue":"2","key":"3508_CR36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.imlet.2009.10.003","volume":"127","author":"F Kovacs-Solyom","year":"2010","unstructured":"Kovacs-Solyom F, Blasko A, Fajka-Boja R, Katona RL, Vegh L, Novak J, Szebeni GJ, Krenacs L, Uher F, Tubak V et al (2010) Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1. Immunol Lett 127(2):108\u2013118","journal-title":"Immunol Lett"},{"issue":"1\u20132","key":"3508_CR37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11010-011-0982-3","volume":"358","author":"C Liu","year":"2011","unstructured":"Liu C, Zhang C, Lu H, Cai J, Wang Z, Chen J, Liu F, Wu Z, Liu X, Sun W (2011) Poly(I:C) induce bone marrow precursor cells into myeloid-derived suppressor cells. Mol Cell Biochem 358(1\u20132):317\u2013323","journal-title":"Mol Cell Biochem"},{"issue":"9","key":"3508_CR38","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4161\/onci.21990","volume":"1","author":"S Danilin","year":"2012","unstructured":"Danilin S, Merkel AR, Johnson JR, Johnson RW, Edwards JR, Sterling JA (2012) Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction. Oncoimmunology 1(9):1484\u20131494","journal-title":"Oncoimmunology"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3508-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-015-3508-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3508-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T13:45:13Z","timestamp":1691847913000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-015-3508-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,25]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["3508"],"URL":"https:\/\/doi.org\/10.1007\/s10549-015-3508-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,25]]}}}